Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review

Nadia Tahouneh; Ramin Ghasemi Shayan

doi:doi:10.11648/j.ijmi.20210904.13

| Peer-Reviewed

Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review

Nadia Tahouneh, Ramin Ghasemi Shayan

Published in International Journal of Medical Imaging (Volume 9, Issue 4)

Received: 21 August 2021 Accepted: 16 September 2021 Published: 5 November 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Coronavirus disease 2019 (COVID-19) with its different symptoms has been widespread throughout the world for about two years and it has brought many deaths in different countries. Although the disease has been reported to target lung tissue as the first option but it can also cause damages in the heart and other tissues of the body. Many researches have been done on how to control and manage this pandemic to prevent further spread of this virus. There is always a percentage chance of error with RT-PCR test, when identifying the COVID-19, which was used as the first method of diagnosing the disease. In emergencies, low sensitivity of RT-PCR could lead to misdiagnosis of this virus. So, different imaging modalities can provide aid to detect the virus more precisely. So far, Radiology imaging especially Chest CT has played an important role in the process of recognizing the disease and in many cases, it has rushed to the aid of the healthcare staff for determining the stages and controlling of the disease. Although a number of countries have made good progress in the field of vaccines, it is very important for staff to know the advantages and disadvantages of each imaging modality in the disease assessment procedures, so that they can use them wisely to accelerate the elimination process of the disease. With this approach, this paper is an overview of various capabilities of different imaging modalities in the field of better management of SARS-CoV-2 disease.

Published in	International Journal of Medical Imaging (Volume 9, Issue 4)
DOI	10.11648/j.ijmi.20210904.13
Page(s)	173-188
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

COVID-19, Helpful Diagnostic Imaging Modalities, Radiography, Chest CT, MRI, Ultrasonography

References

[1]	Mossa-Basha M, Meltzer CC, Kim DC, Tuite MJ, Kolli KP, Tan BS. Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Review Panel. Radiology. 2020; 296 (2): E106-E12.
[2]	Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020; 296 (2): E15-E25.
[3]	Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic Coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. Journal of Medical Virology. 2020; 92 (5): 491-4.
[4]	He F, Deng Y, Li W. Coronavirus disease 2019: What we know? Journal of medical virology. 2020; 92 (7): 719-25.
[5]	Jajodia A, Ebner L, Heidinger B, Chaturvedi A, Prosch H. Imaging in corona virus disease 2019 (COVID-19)—A Scoping review. European Journal of Radiology Open. 2020; 7: 100237.
[6]	Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323 (13): 1239-42.
[7]	Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020; 296 (2): E32-E40.
[8]	Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv. 2020: 2020.02.11.20021493.
[9]	Castillo F, Bazaes D, Huete Á. Radiology in the COVID-19 Pandemic: Current role, recommendations for structuring the radiological report and our Departments experience. Rev Chil Radiol. 2020; 26 (3): 88-99.
[10]	WHO. nCoV/Clinical/Radiology_imaging/2020.1: https://www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19; 2019.
[11]	World Health O. Coronavirus disease (‎‎COVID-19)‎‎ outbreak: rights, roles and responsibilities of health workers, including key considerations for occupational safety and health: interim guidance, 19 March 2020. Geneva: World Health Organization; 2020 2020. Contract No.: WHO/2019-nCov/HCW_advice/2020.2.
[12]	https://www.iaea.org. Radiation Protection and Safety in Medical Uses of Ionizing Radiation Specific Safety Guide: https://www.iaea.org/publications/11102/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation; 2020.
[13]	Aljondi R, Alghamdi S. Diagnostic Value of Imaging Modalities for COVID-19: Scoping Review. J Med Internet Res. 2020; 22 (8): e19673.
[14]	Fields BKK, Demirjian NL, Dadgar H, Gholamrezanezhad A. Imaging of COVID-19: CT, MRI, and PET. Semin Nucl Med. 2020.
[15]	Dong D, Tang Z, Wang S, Hui H, Gong L, Lu Y, et al. The Role of Imaging in the Detection and Management of COVID-19: A Review. IEEE Reviews in Biomedical Engineering. 2021; 14: 16-29.
[16]	Liszewski MC, Görkem S, Sodhi KS, Lee EY. Lung magnetic resonance imaging for pneumonia in children. Pediatric Radiology. 2017; 47 (11): 1420-30.
[17]	Jacobi A, Chung M, Bernheim A, Eber C. PorTable chest X-ray in Coronavirus disease-19 (COVID-19): A pictorial review. Clin Imaging. 2020; 64: 35-42.
[18]	Wong HYF, Lam HYS, Fong AH-T, Leung ST, Chin TW-Y, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020; 296 (2): E72-E8.
[19]	Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest radiographic and CT findings of the 2019 novel Coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean journal of radiology. 2020; 21 (4): 494.
[20]	Manych M. X-ray imaging for COVID-19 patients: https://www.siemens-healthineers.com/news/mso-x-ray-imaging-for-covid-19.html; 2020-05-15.
[21]	Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. Chest. 2020; 158 (1): 106-16.
[22]	Oliva DLFDG. COVID-19 - pneumothorax: https://radiopaedia.org/cases/covid-19-pneumothorax; 2020.
[23]	Kong W, Agarwal PP. Chest Imaging Appearance of COVID-19 Infection. Radiology: Cardiothoracic Imaging. 2020; 2 (1): e200028.
[24]	Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395 (10223): 507-13.
[25]	Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. doi: 10.1016/S0140-6736(20)30183-5.
[26]	Aydin S, Oz G, Dumanli A, Balcı A, Gencer A. A Case of Spontaneous Pneumothorax in Covid-19 Pneumonia. Journal of Surgery and Research. 2020; 03.
[27]	Lorente DE. COVID-19 infection - exclusive gastrointestinal symptoms: https://radiopaedia.org/cases/covid-19-infection-exclusive-gastrointestinal-symptoms; 2020.
[28]	Julia Tran M, Justin Glavis-Bloom M, Theodore Bryan M, Karen Tran Harding M, Chantal Chahine M, Roozbeh Houshyar M. COVID-19 patient presenting with initial gastrointestinal symptoms: https://www.eurorad.org/case/16654; 2020.
[29]	Bickle DI, Bell DDJ, al e. COVID-19: https://radiopaedia.org/articles/covid-19-4; 2020.
[30]	Rodrigues JCL, Hare SS, Edey A, Devaraj A, Jacob J, Johnstone A, et al. An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement. Clin Radiol. 2020; 75 (5): 323-5.
[31]	van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface STable ility of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020; 382 (16): 1564-7.
[32]	ACR. ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection: https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection; 2020.
[33]	ACR. ACR Information on Field Radiology Care During the COVID-19 Pandemic: https://www.acr.org/Advocacy-and-Economics/Advocacy-News/Advocacy-News-Issues/In-the-April-4-2020-Issue/ACR-Information-on-Field-Radiology-Care-During-the-COVID-19-Pandemic; 2020.
[34]	Rousan LA, Elobeid E, Karrar M, Khader Y. Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia. BMC Pulmonary Medicine. 2020; 20 (1): 245.
[35]	Lei Y, Zhang H-W, Yu J, Patlas MN. COVID-19 Infection: Early Lessons. Canadian Association of Radiologists Journal. 2020; 71 (3): 251-2.
[36]	Zhang J, Tian S, Lou J, Chen Y. Familial cluster of COVID-19 infection from an asymptomatic. Critical Care. 2020; 24 (1): 119.
[37]	Smith DL, Grenier J-P, Batte C, Spieler B. A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic. Radiology: Cardiothoracic Imaging. 2020; 2 (5): e200280.
[38]	Revel M-P, Parkar AP, Prosch H, Silva M, Sverzellati N, Gleeson F, et al. COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). European radiology. 2020; 30 (9): 4903-9.
[39]	Thieba C, Frayne A, Walton M, Mah A, Benischek A, Dewey D, et al. Factors Associated With Successful MRI Scanning in Unsedated Young Children. Front Pediatr. 2018; 6: 146.
[40]	Benefits and Risks. FDA. 2017.
[41]	MRI. Cancer Quest 2021.
[42]	Itoh S, lkeda M, Arahata S, et al: Lung cancer screening: Minimum tube current required for helical CT. Radiology 215: 175-183, 2000.
[43]	"COVID-19 Updates". Ranzcr.com, [Link]. https://www.ranzcr.com/our-work/coronavirus 2020.
[44]	RANZCR. COVID-19 Updates: https://www.ranzcr.com/our-work/Coronavirus; 2020.
[45]	Manna S, Wruble J, Maron SZ, Toussie D, Voutsinas N, Finkelstein M, et al. COVID-19: A Multimodality Review of Radiologic Techniques, Clinical Utility, and Imaging Features. Radiology: Cardiothoracic Imaging. 2020; 2 (3): e200210.
[46]	Kligerman SJ, Franks TJ, Galvin JR. From the Radiologic Pathology Archives: Organization and Fibrosis as a Response to Lung Injury in Diffuse Alveolar Damage, Organizing Pneumonia, and Acute Fibrinous and Organizing Pneumonia. RadioGraphics. 2013; 33 (7): 1951-75.
[47]	Güneyli S, Atçeken Z, Doğan H, Altınmakas E, Atasoy KÇ. Radiological approach to COVID-19 pneumonia with an emphasis on Chest CT. Diagn Interv Radiol. 2020; 26 (4): 323-32.
[48]	Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020; 126: 108961.
[49]	Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. 2020; 296 (2): E115-E7.
[50]	Wen Z, Chi Y, Zhang L, Liu H, Du K, Li Z, et al. Coronavirus Disease 2019: Initial Detection on Chest CT in a Retrospective Multicenter Study of 103 Chinese Patients. Radiology: Cardiothoracic Imaging. 2020; 2 (2): e200092.
[51]	Raptis CA, Hammer MM, Short RG, Shah A, Bhalla S, Bierhals AJ, et al. Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date. American Journal of Roentgenology. 2020; 215 (4): 839-42.
[52]	Rizk DO. COVID-19 pneumonia: https://radiopaedia.org/cases/covid-19-pneumonia-139?lan; 2020.
[53]	Samir DA. Acute appendicitis and COVID-19 pneumonia: https://radiopaedia.org/cases/acute-appendicitis-and-covid-19-pneumonia?lang=us; 2020.
[54]	Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiology: Cardiothoracic Imaging. 2020; 2 (2): e200152.
[55]	Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT. Radiology. 2020; 296 (2): E46-E54.
[56]	Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G, et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagnostic and Interventional Imaging. 2020; 101 (5): 263-8.
[57]	Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. American Journal of Roentgenology. 2020; 215 (1): 87-93.
[58]	Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, et al. CT image visual quantitative evaluation and clinical classification of Coronavirus disease (COVID-19). European Radiology. 2020; 30 (8): 4397-16.
[59]	Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020; 295 (3): 715-21.
[60]	Z Na, Z Ding, W Wen, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395 (2020), pp. 497-605.
[61]	Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020; 55 (6): 327-31.
[62]	Hamer OW, Salzberger B, Gebauer J, Stroszczynski C, Pfeifer M. CT morphology of COVID-19: Case report and review of literature. Rofo. 2020; 192 (5): 386-92.
[63]	Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020; 295 (1): 202-7.
[64]	Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020; 295 (3): 200463.
[65]	Asefi H, Safaie A. The role of Chest CT scan in diagnosis of COVID-19. Frontiers in Emergency Medicine. 2020; 4 (2s): e64-e.
[66]	Kord A, Rabiee B, Wang S, Rostami S, Gaba RC, Xie KL. A Concise Review and Required Precautions for COVID-19 Outbreak in Diagnostic and Interventional Radiology. Radiology Research and Practice. 2020; 2020: 7159091.
[67]	Wang K, Kang S, Tian R, Zhang X, Zhang X, Wang Y. Imaging manifestations and diagnostic value of Chest CT of Coronavirus disease 2019 (COVID-19) in the Xiaogan area. Clin Radiol. 2020; 75 (5): 341-7.
[68]	Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel Coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. European Radiology. 2020; 30 (6): 3306-9.
[69]	Zhao W, Zhong Z, Xie X, Yu Q, Liu J. CT Scans of Patients with 2019 Novel Coronavirus (COVID-19) Pneumonia. Theranostics. 2020; 10 (10): 4606-13.
[70]	Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases. 2020; 20 (4): 425-34.
[71]	Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020; 295 (1): 210-7.
[72]	Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR Am J Roentgenol. 2020; 214 (6): 1280-6.
[73]	Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update—Radiology Scientific Expert Panel. Radiology. 2020; 296 (2): E113-E4.
[74]	Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. European radiology. 2020; 30 (12): 6808-17.
[75]	Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, et al. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. Radiol Cardiothorac Imaging. 2020; 2 (2): e200047.
[76]	Hafez MAF. The mean severity score and its correlation with common computed tomography chest manifestations in Egyptian patients with COVID-2019 pneumonia. The Egyptian Journal of Radiology and Nuclear Medicine. 2020; 51 (1): 254.
[77]	Zhou S, Wang Y, Zhu T, Xia L. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. American Journal of Roentgenology. 2020; 214: 1-8.
[78]	Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. American Journal of Roentgenology. 2020; 214 (5): 1072-7.
[79]	Araujo-Filho JdAB, Sawamura MVY, Costa AN, Cerri GG, Nomura CH. COVID-19 pneumonia: what is the role of imaging in diagnosis? Jornal Brasileiro de Pneumologia. 2020; 46.
[80]	Hao W, Li M. Clinical diagnostic value of CT imaging in COVID-19 with multiple negative RT-PCR testing. Travel Med Infect Dis. 2020; 34: 101627.
[81]	Chua F, Armstrong-James D, Desai SR, Barnett J, Kouranos V, Kon OM, et al. The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions. Lancet Respir Med. 2020; 8 (5): 438-40.
[82]	Yang W, Yan F. Patients with RT-PCR-confirmed COVID-19 and Normal Chest CT. Radiology. 2020; 295 (2): E3.
[83]	Wang YXJ, Liu W-H, Yang M, Chen W. The role of CT for Covid-19 patient's management remains poorly defined. Ann Transl Med. 2020; 8 (4): 145.
[84]	Hall E. Lessons we have learned from our children: Cancer risk from diagnostic radiology. Pediatric radiology. 2002; 32: 700-6.
[85]	Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. Bmj. 2013; 346: f2360.
[86]	Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. 2020; 382 (10): 929-36.
[87]	Jin S, Zhang B, Zhang L, Li S, Li S, Li P. Lung nodules assessment in ultra-low-dose CT with iterative reconstruction compared to conventional dose CT. Quantitative Imaging in Medicine and Surgery. 2018; 8 (5): 480-90.
[88]	Kalra MK, Maher MM, Rizzo S, Kanarek D, Shepard J-AO. Radiation exposure from Chest CT: issues and strategies. J Korean Med Sci. 2004; 19 (2): 159-66.
[89]	School HM. Radiation risk from medical imaging: https://www.health.harvard.edu/cancer/radiation-risk-from-medical-imaging; 2020.
[90]	FDA. What are the Radiation Risks from CT?: https://www.fda.gov/radiation-emitting-products/medical-x-ray-imaging/what-are-radiation-risks-ct; 12/05/2017.
[91]	ACR. ACR Guidance on COVID-19 and MR Use: https://www.acr.org/Clinical-Resources/Radiology-Safety/MR-Safety/COVID-19-and-MR-Use; 2020.
[92]	FDA. Wear Face Masks with No Metal During MRI Exams: FDA Safety Communication: https://www.fda.gov/medical-devices/safety-communications/wear-face-masks-no-metal-during-mri-exams-fda-safety-communication; 01/07/2021.
[93]	Kooraki S, Hosseiny M, Raman SS, Myers L, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19) Precautions: What the MRI Suite Should Know. J Am Coll Radiol. 2020; 17 (7): 830.
[94]	Adhikari U, Chabrelie A, Weir M, Boehnke K, McKenzie E, Ikner L, et al. A Case Study Evaluating the Risk of Infection from Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) in a Hospital Setting Through Bioaerosols. Risk Anal. 2019; 39 (12): 2608-24.
[95]	Ates OF, Taydas O, Dheir H. Thorax Magnetic Resonance Imaging Findings in Patients with Coronavirus Disease (COVID-19). Acad Radiol. 2020; 27 (10): 1373-8.
[96]	Barentsz J, Takahashi S, Oyen W, Mus R, De Mulder P, Reznek R, et al. Commonly used imaging techniques for diagnosis and staging. J Clin Oncol. 2006; 24 (20): 3234-44.
[97]	Meier-Schroers M, Kukuk G, Homsi R, Skowasch D, Schild HH, Thomas D. MRI of the lung using the PROPELLER technique: Artifact reduction, better image quality and improved nodule detection. Eur J Radiol. 2016; 85 (4): 707-13.
[98]	Galougahi MK, Ghorbani J, Bakhshayeshkaram M, Naeini AS, Haseli S. Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report. Acad Radiol. 2020; 27 (6): 892-3.
[99]	Mossa-Basha M, Medverd J, Linnau KF, Lynch JB, Wener MH, Kicska G, et al. Policies and Guidelines for COVID-19 Preparedness: Experiences from the University of Washington. Radiology. 2020; 296 (2): E26-E31.
[100]	Torkian P, Rajebi H, Zamani T, Ramezani N, Kiani P, Akhlaghpoor S. Magnetic resonance imaging features of Coronavirus disease 2019 (COVID-19) pneumonia: The first preliminary case series. Clin Imaging. 2021; 69: 261-5.
[101]	Gulko E, Oleksk ML, Gomes W, Ali S, Mehta H, Overby P, et al. MRI Brain Findings in 126 Patients with COVID-19: Initial Observations from a Descriptive Literature Review. American Journal of Neuroradiology. 2020; 41 (12): 2199.
[102]	Yang S, Zhang Y, Shen J, Dai Y, Ling Y, Lu H, et al. Clinical Potential of UTE-MRI for Assessing COVID-19: Patient- and Lesion-Based Comparative Analysis. Journal of Magnetic Resonance Imaging. 2020; 52 (2): 397-406.
[103]	Syrjala H, Broas M, Ohtonen P, Jartti A, Pääkkö E. Chest magnetic resonance imaging for pneumonia diagnosis in outpatients with lower respiratory tract infection. European Respiratory Journal. 2017; 49 (1): 1601303.
[104]	Caro-Dominguez P, Shelmerdine SC, Toso S, Secinaro A, Toma P, Damasio MB, et al. Thoracic imaging of Coronavirus disease 2019 (COVID-19) in children: a series of 91 cases. Pediatric Radiology. 2020; 50 (10): 1354-68.
[105]	Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020; 49 (5): 411-7.
[106]	Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020; 5 (7): 819-24.
[107]	Gargani L, Pang PS, Frassi F, Miglioranza MH, Dini FL, Landi P, et al. Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung Ultrasound study. Cardiovasc Ultrasound. 2015; 13: 40.
[108]	Lichtenstein DA. BLUE-Protocol and FALLS-Protocol: Two Applications of Lung Ultrasound in the Critically Ill. Chest. 2015; 147 (6): 1659-70.
[109]	Lichtenstein DA. Lung Ultrasound in the critically ill. Ann Intensive Care. 2014; 4 (1): 1.
[110]	Efremov SM, Kuzkov VV, Fot EV, Kirov MY, Ponomarev DN, Lakhin RE, et al. Lung Ultrasonography and cardiac surgery: a narrative review. Journal of cardiothoracic and vascular anesthesia. 2020; 34 (11): 3113-24.
[111]	Kremer, S., et al., Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology, 2020. 297 (2): p. E242-E251.

Cite This Article

Plain Text BibTeX RIS

APA Style

Nadia Tahouneh, Ramin Ghasemi Shayan. (2021). Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review. International Journal of Medical Imaging, 9(4), 173-188. https://doi.org/10.11648/j.ijmi.20210904.13

Copy | Download

ACS Style

Nadia Tahouneh; Ramin Ghasemi Shayan. Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review. Int. J. Med. Imaging 2021, 9(4), 173-188. doi: 10.11648/j.ijmi.20210904.13

Copy | Download

AMA Style

Nadia Tahouneh, Ramin Ghasemi Shayan. Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review. Int J Med Imaging. 2021;9(4):173-188. doi: 10.11648/j.ijmi.20210904.13

Copy | Download

@article{10.11648/j.ijmi.20210904.13,
  author = {Nadia Tahouneh and Ramin Ghasemi Shayan},
  title = {Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review},
  journal = {International Journal of Medical Imaging},
  volume = {9},
  number = {4},
  pages = {173-188},
  doi = {10.11648/j.ijmi.20210904.13},
  url = {https://doi.org/10.11648/j.ijmi.20210904.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20210904.13},
  abstract = {Coronavirus disease 2019 (COVID-19) with its different symptoms has been widespread throughout the world for about two years and it has brought many deaths in different countries. Although the disease has been reported to target lung tissue as the first option but it can also cause damages in the heart and other tissues of the body. Many researches have been done on how to control and manage this pandemic to prevent further spread of this virus. There is always a percentage chance of error with RT-PCR test, when identifying the COVID-19, which was used as the first method of diagnosing the disease. In emergencies, low sensitivity of RT-PCR could lead to misdiagnosis of this virus. So, different imaging modalities can provide aid to detect the virus more precisely. So far, Radiology imaging especially Chest CT has played an important role in the process of recognizing the disease and in many cases, it has rushed to the aid of the healthcare staff for determining the stages and controlling of the disease. Although a number of countries have made good progress in the field of vaccines, it is very important for staff to know the advantages and disadvantages of each imaging modality in the disease assessment procedures, so that they can use them wisely to accelerate the elimination process of the disease. With this approach, this paper is an overview of various capabilities of different imaging modalities in the field of better management of SARS-CoV-2 disease.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review
AU  - Nadia Tahouneh
AU  - Ramin Ghasemi Shayan
Y1  - 2021/11/05
PY  - 2021
N1  - https://doi.org/10.11648/j.ijmi.20210904.13
DO  - 10.11648/j.ijmi.20210904.13
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 173
EP  - 188
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20210904.13
AB  - Coronavirus disease 2019 (COVID-19) with its different symptoms has been widespread throughout the world for about two years and it has brought many deaths in different countries. Although the disease has been reported to target lung tissue as the first option but it can also cause damages in the heart and other tissues of the body. Many researches have been done on how to control and manage this pandemic to prevent further spread of this virus. There is always a percentage chance of error with RT-PCR test, when identifying the COVID-19, which was used as the first method of diagnosing the disease. In emergencies, low sensitivity of RT-PCR could lead to misdiagnosis of this virus. So, different imaging modalities can provide aid to detect the virus more precisely. So far, Radiology imaging especially Chest CT has played an important role in the process of recognizing the disease and in many cases, it has rushed to the aid of the healthcare staff for determining the stages and controlling of the disease. Although a number of countries have made good progress in the field of vaccines, it is very important for staff to know the advantages and disadvantages of each imaging modality in the disease assessment procedures, so that they can use them wisely to accelerate the elimination process of the disease. With this approach, this paper is an overview of various capabilities of different imaging modalities in the field of better management of SARS-CoV-2 disease.
VL  - 9
IS  - 4
ER  -

Copy | Download

Author Information

Nadia Tahouneh

Radiology Department, Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
Ramin Ghasemi Shayan

Radiology Department, Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Nadia Tahouneh, Ramin Ghasemi Shayan. (2021). Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review. International Journal of Medical Imaging, 9(4), 173-188. https://doi.org/10.11648/j.ijmi.20210904.13

Copy | Download

ACS Style

Nadia Tahouneh; Ramin Ghasemi Shayan. Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review. Int. J. Med. Imaging 2021, 9(4), 173-188. doi: 10.11648/j.ijmi.20210904.13

Copy | Download

AMA Style

Nadia Tahouneh, Ramin Ghasemi Shayan. Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review. Int J Med Imaging. 2021;9(4):173-188. doi: 10.11648/j.ijmi.20210904.13

Copy | Download

@article{10.11648/j.ijmi.20210904.13,
  author = {Nadia Tahouneh and Ramin Ghasemi Shayan},
  title = {Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review},
  journal = {International Journal of Medical Imaging},
  volume = {9},
  number = {4},
  pages = {173-188},
  doi = {10.11648/j.ijmi.20210904.13},
  url = {https://doi.org/10.11648/j.ijmi.20210904.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20210904.13},
  abstract = {Coronavirus disease 2019 (COVID-19) with its different symptoms has been widespread throughout the world for about two years and it has brought many deaths in different countries. Although the disease has been reported to target lung tissue as the first option but it can also cause damages in the heart and other tissues of the body. Many researches have been done on how to control and manage this pandemic to prevent further spread of this virus. There is always a percentage chance of error with RT-PCR test, when identifying the COVID-19, which was used as the first method of diagnosing the disease. In emergencies, low sensitivity of RT-PCR could lead to misdiagnosis of this virus. So, different imaging modalities can provide aid to detect the virus more precisely. So far, Radiology imaging especially Chest CT has played an important role in the process of recognizing the disease and in many cases, it has rushed to the aid of the healthcare staff for determining the stages and controlling of the disease. Although a number of countries have made good progress in the field of vaccines, it is very important for staff to know the advantages and disadvantages of each imaging modality in the disease assessment procedures, so that they can use them wisely to accelerate the elimination process of the disease. With this approach, this paper is an overview of various capabilities of different imaging modalities in the field of better management of SARS-CoV-2 disease.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Comprehensive Evaluation of Multimodality Imaging in SARS-CoV-2 Patients: A Review
AU  - Nadia Tahouneh
AU  - Ramin Ghasemi Shayan
Y1  - 2021/11/05
PY  - 2021
N1  - https://doi.org/10.11648/j.ijmi.20210904.13
DO  - 10.11648/j.ijmi.20210904.13
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 173
EP  - 188
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20210904.13
AB  - Coronavirus disease 2019 (COVID-19) with its different symptoms has been widespread throughout the world for about two years and it has brought many deaths in different countries. Although the disease has been reported to target lung tissue as the first option but it can also cause damages in the heart and other tissues of the body. Many researches have been done on how to control and manage this pandemic to prevent further spread of this virus. There is always a percentage chance of error with RT-PCR test, when identifying the COVID-19, which was used as the first method of diagnosing the disease. In emergencies, low sensitivity of RT-PCR could lead to misdiagnosis of this virus. So, different imaging modalities can provide aid to detect the virus more precisely. So far, Radiology imaging especially Chest CT has played an important role in the process of recognizing the disease and in many cases, it has rushed to the aid of the healthcare staff for determining the stages and controlling of the disease. Although a number of countries have made good progress in the field of vaccines, it is very important for staff to know the advantages and disadvantages of each imaging modality in the disease assessment procedures, so that they can use them wisely to accelerate the elimination process of the disease. With this approach, this paper is an overview of various capabilities of different imaging modalities in the field of better management of SARS-CoV-2 disease.
VL  - 9
IS  - 4
ER  -

Copy | Download